Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 6.43B | 6.78B | 7.94B | 5.93B | 4.00B |
Gross Profit | 2.46B | 1.90B | 2.32B | 1.85B | 1.31B |
EBITDA | 7.78B | 10.47B | 19.15B | 7.75B | 4.03B |
Net Income | 2.85B | 4.33B | 12.22B | 5.30B | 3.10B |
Balance Sheet | |||||
Total Assets | 62.27B | 65.50B | 71.32B | 53.82B | 36.32B |
Cash, Cash Equivalents and Short-Term Investments | 19.26B | 20.63B | 13.14B | 6.12B | 8.17B |
Total Debt | 16.50B | 16.45B | 16.15B | 8.27B | 3.86B |
Total Liabilities | 20.99B | 20.89B | 21.19B | 12.96B | 6.39B |
Stockholders Equity | 17.87B | 18.96B | 20.58B | 29.19B | 21.75B |
Cash Flow | |||||
Free Cash Flow | 936.00M | -479.00M | -981.00M | -62.00M | -310.00M |
Operating Cash Flow | 1.03B | -177.00M | -702.00M | 73.00M | -196.00M |
Investing Cash Flow | 142.00M | 12.55B | 5.91B | -731.00M | 2.32B |
Financing Cash Flow | -8.24B | -12.10B | 894.00M | 53.00M | 6.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $24.72B | 13.10 | 48.41% | ― | 17.81% | 1175.52% | |
75 Outperform | $26.72B | 223.25 | 5.77% | ― | 64.12% | ― | |
75 Outperform | $31.64B | 8.68 | 9.85% | ― | -1.33% | 32.92% | |
73 Outperform | $100.33B | 306.62 | 4.41% | ― | 23.35% | ― | |
72 Outperform | $32.02B | 26.11 | 14.37% | 0.84% | 4.59% | 83.27% | |
63 Neutral | $50.15B | 10.08 | 26.41% | 0.15% | 11.37% | ― | |
62 Neutral | $40.93B | -1.67 | -12.06% | 3.96% | 2.10% | -69.66% |